The Magazine for Sleep Professionals
Friday, July 24, 2026
In a new paper published online in the Annals of the American Thoracic Society, researchers have been unable to produce two theorized subphenotypes of COVID-19 related acute respiratory distress syndrome (ARDS). Scientists previously proposed that two phenotypes exist that differentiate patients with more severe COVID-19 and indicate that they should be treated […]
Today, the American Thoracic Society announced a $100,000 donation from Gilead Sciences, Inc. to support the ATS COVID-19 Crisis Fund. This donation from Gilead is the latest in a highly appreciated increase in funding support from industry. The ATS COVID-19 Crisis Fund aims to develop and disseminate research, education and scientific recommendations […]
An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment. The new guidance – “COVID-19: Interim Guidance on Management Pending Empirical Evidence”– is published as an open-access document on […]
Boehringer Ingelheim Pharmaceuticals, Inc., donated $500,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. […]
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Time Kinetics of […]
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Reduction in All-Cause Mortality […]
Traditional stoves that burn biomass materials and are not properly ventilated, which are widely used in developing nations where cooking is done indoors, have been shown to significantly increase indoor levels of harmful PM2.5 (minuscule atmospheric particulates) and carbon monoxide (CO) and to stimulate biological processes that cause lung inflammation and […]
While deaths steadily declined over a decade in intensive care units at hospitals with few minority patients, in ICUs with large numbers of minority patients, there was less improvement, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. The disparity was most […]
The number of people newly infected each year and the number of people living with nontuberculous mycobacterial lung disease appears to be increasing, especially among women and those 65 and older, according to new research published online in the Annals of the American Thoracic Society. In “Incidence and Prevalence of Nontuberculous […]
Reductions in air pollution yielded fast and dramatic impacts on health outcomes, as well as decreases in all-cause morbidity, according to findings in “Health Benefits of Air Pollution Reduction,” new research published in the American Thoracic Society’s journal, Annals of the American Thoracic Society. The study by the Environmental Committee of the Forum […]
